EUVIMEDEUVIMED entdecken
Crossref

Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions

Yue Zhou, Fang Zhang, Akihiro Tanaka, Takahiro Yokota, Satoru Yokoyama, Seiji Yano, Hiroaki Sakurai

Biological and Pharmaceutical Bulletin · 2025

DOI: 10.1248/bpb.b25-00324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Yue Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Cell Biology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Toyama 930-0194, Japan. Hauptthemen laut MEDLINE: Ribosomal Protein S6 Kinases, 90-kDa, Cell Movement, Receptor, EphA2. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

p90 ribosomal S6 kinase 1 (RSK1) regulates various cellular events involved in cell growth and migration. We previously demonstrated that RSK1 catalyzes ephrin receptor A2 (EphA2) phosphorylation at Ser-897 to promote cancer cell migration, and that this pathway is regulated independently by extracellular signal-regulated kinase (ERK) and mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2). Although the activation mechanism of RSK1 via ERK has been extensively examined, the mechanism for MK2 remains unclear. In the present study, we showed that MK2-mediated phosphorylation at Ser-380 in the linker region, a key mechanism of RSK1 activation, was dependent on the basal phosphorylation of Ser-221 in the N-terminal kinase domain. This basal phosphorylation was catalyzed by 3-phosphoinositide-dependent kinase 1 (PDK1) and was independent of ERK-catalyzed Ser-380 phosphorylation. The PDK1-MK2-RSK1-EphA2 axis promoted glioblastoma cell migration induced by temozolomide, a chemotherapeutic agent. Collectively, these results reveal a novel activation mechanism of RSK1 in cancer malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ribosomal Protein S6 Kinases, 90-kDaCell MovementReceptor, EphA2HumansPhosphorylationCell Line, TumorProtein Serine-Threonine KinasesStress, Physiological

Stichwörter der Autor:innen

cell migrationephrin receptor A2mitogen-activated protein kinase-activated protein kinase 2p90 ribosomal S6 kinase 1

Substanzen

Ribosomal Protein S6 Kinases, 90-kDaReceptor, EphA2Protein Serine-Threonine Kinasesribosomal protein S6 kinase, 90kDa, polypeptide 3EPHA2 protein, humanRPS6KA1 protein, human

Autor:innen und Institutionen

  • Department of Cancer Cell Biology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Toyama 930-0194, Japan.
  • Department of Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Science, Kanazawa University, Takara-machi, Kanazawa, Ishikawa 920-0934, Japan.

Zitieren

APA

Zhou, Y., Zhang, F., Tanaka, A., Yokota, T., Yokoyama, S., Yano, S., & Sakurai, H. (2025). Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00324

Vancouver

Zhou Y, Zhang F, Tanaka A, Yokota T, Yokoyama S, Yano S, et al. Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00324

BibTeX
@article{Zhou2025,
  author = {Zhou, Yue and Zhang, Fang and Tanaka, Akihiro and Yokota, Takahiro and Yokoyama, Satoru and Yano, Seiji and Sakurai, Hiroaki},
  title = {Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/bpb.b25-00324}
}
Kostenlos starten →